Clonidine-induced hypertension in a patient with a spinal lesion.
OBJECTIVE
To report a case of possible clonidine-induced hypertension (by Naranjo score) in a patient with a C4 spinal lesion.


BACKGROUND
Clonidine is a medication long used to treat hypertension, and it is still used in the treatment of refractory hypertension. Although effective, clonidine use is hindered by adverse effects and its dual mechanism of action.


METHODS
A 39-year-old white, quadriplegic man with poorly controlled pain displayed many characteristics consistent with autonomic dysfunction (e.g., C4 spinal lesion, orthostatic hypotension, hypertension). The patient was routinely receiving transdermal clonidine and also received transdermal nitroglycerin paste as needed for control of acute hypertensive episodes. On the recommendation of the home healthcare pharmacists, clonidine was discontinued. Since that time, the patient's blood pressure and the use of emergent antihypertensive treatment have decreased significantly (maximum systolic and diastolic BP by approximately 50 and 25 mm Hg, respectively).


CONCLUSIONS
Many of the characteristics of autonomic dysfunction, such as refractory hypertension, can seem selective for the use of clonidine and, because of its reliance on central alpha(2)-activity for its hypotensive effects, clonidine may induce hypertension in patients with autonomic dysfunction. Clonidine should be used with great caution when autonomic dysfunction is suspected.
Backo
Angel L
AL
Albany College of Pharmacy, Albany, NY 12208-3492, USA.
Clause
Steven L
SL
Triller
Darren M
DM
Gibbs
Karen A
KA
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D003000:Clonidine / Q000009:adverse effects* / Q000627:therapeutic use; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010147:Pain Measurement; D010264:Paraplegia / Q000150:complications; D013119:Spinal Cord Injuries / Q000150:complications*; D000077236:Topiramate
D000316:Adrenergic alpha-Agonists; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose; D003000:Clonidine